Gene therapy of muscular dystrophy

Human Molecular Genetics

Volumn 11, Issue 20, 2002, Pages 2355-2362

  Chamberlain, Jeffrey S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTISENSE OLIGONUCLEOTIDE; BETA GALACTOSIDASE; COMPLEMENTARY DNA; CREATINE KINASE; DYSTROPHIN; GLYCOPROTEIN; HISTAMINE; MESSENGER RNA; NAKED DNA; PAPAVERINE; PLASMID DNA; SARCOGLYCAN; UTROPHIN; VASODILATOR AGENT; VIRUS VECTOR;

CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SKELETAL MUSCLE;

EID: 0036796262     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.20.2355     Document Type: Review

References (111)

1. Emery, A.E. (2002) The muscular dystrophies. Lancet, 359, 687-695.
2. Hoffman, E.P., Brown, R.H., Jr. and Kunkel, L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
3. Ervasti, J.M. and Campbell, K.P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol., 122, 809-823.
4. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. and Sweeney, H.L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA, 90, 3710-3714.
5. Lynch, G.S., Rafael, J.A., Chamberlain, J.S. and Faulkner, J.A. (2000) Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice. Am. J. Physiol. Cell Physiol., 279, C1290-C1294.
6. Blake, D.J., Weir, A., Newey, S.E. and Davies, K.E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev., 82, 291-329.
7. Piccolo, F., Moore, S.A., Mathews, K.D. and Campbell, K.P. (2002) Limb-girdle muscular dystrophies. Adv. Neurol., 88, 273-291.
8. Helbling-Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, J., Tome, F.M., Schwartz, K., Fardeau, M. and Tryggvason, K. (1995) Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet., 11, 216-218.
9. Bulfield, G., Siller, W.G., Wight, P.A. and Moore, K.J. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl Acad. Sci. USA, 81, 1189-1192.
10. Chapman, V.M., Miller, D.M., Armstrong, D. and Caskey, C.T. (1989) Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc. Natl. Acad. Sci. USA, 86, 1292-1296.
11. Cooper, B.J., Winand, N.J., Stedman, H., Valentine, B.A., Hoffman, E.P., Kunkel, L.M., Scott, M.O., Fischbeck, K.H., Kornegay, J.N. and Avery, R.J. (1988) The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature, 334, 154-156.
12. Cox, G.A., Cole, N.M., Matsumura, K., Phelps, S.F., Hauschka, S.D., Campbell, K.P., Faulkner, J.A. and Chamberlain, J.S. (1993) Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature, 364, 725-729.
13. Phelps, S.F., Hauser, M.A., Cole, N.M., Rafael, J.A., Hinkle, R.T., Faulkner, J.A. and Chamberlain, J.S. (1995) Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum. Mol. Genet., 4, 1251-1258.
14. Wells, D.J., Wells, K.E., Asante, E.A., Turner, G., Sunada, Y., Campbell, K.P., Walsh, F.S. and Dickson, G. (1995) Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy. Hum. Mol. Genet., 4, 1245-1250.
15. Ohlendieck, K. and Campbell, K.P. (1991) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell Biol., 115, 1685-1694.
16. Cox, G.A., Sunada, Y., Campbell, K.P. and Chamberlain, J.S. (1994) Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat. Genet., 8, 333-339.
17. Greenberg, D.S., Sunada, Y., Campbell, K.P., Yaffe, D. and Nudel, U. (1994) Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat. Genet., 8, 340-344.
18. Rafael, J.A., Townsend, E.R., Squire, S.E., Potter, A.C., Chamberlain, J.S. and Davies, K.E. (2000) Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure. Hum. Mol. Genet., 9, 1357-1367.
19. Warner, L.E., Dello Russo, C., Crawford, R., Rybakova, I., Patel, I., Ervasti, J. and Chamberlain, J. (2002) Expression of Dp260 in muscle tethers the actin cytoskeletan to the dystrophin-glycoprotein complex. Hum. Mol. Genet., 11, 1095-1105.
20. Koenig, M., Beggs, A.H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Muller, C.R., Lindlof, M., Kaariainen, H. et al. (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet., 45, 498-506.
21. England, S.B., Nicholson, L.V, Johnson, M.A., Forrest, S.M., Love, D.R., Zubrzycka-Gaarn, E.E., Bulman, D.E., Harris, J.B. and Davies, K.E. (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature, 343, 180-182.
22. McCabe, E.R., Towbin, J., Chamberlain, J., Baumbach, L., Witkowski, J., van Ommen, G.J., Koenig, M., Kunkel, L.M. and Seltzer, W.K. (1989) Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia. J. Clin. Invest., 83, 95-99.
23. Rafael, J.A., Cox, G.A., Corrado, K., Jung, D., Campbell, K.P. and Chamberlain, J.S. (1996) Forced expression of dystrophin deletion constructs reveals structure-function correlations. J. Cell Biol., 134, 93-102.
24. Crawford, G.E., Faulkner, J.A., Crosbie, R.H., Campbell, K.P., Froehner, S.C. and Chamberlain, J.S. (2000) Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J. Cell Biol., 150, 1399-1410.
25. Yuasa, K., Miyagoe, Y., Yamamoto, K., Nabeshima, Y., Dickson, G. and Takeda, S. (1998) Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs. FEBS Lett., 425, 329-336.
26. Sakamoto, M., Yuasa, K., Yoshimura, M., Yokota, T., Ikemoto, T., Suzuki, M., Dickson, G., Miyagoe-Suzuki, Y. and Takeda, S. (2002) Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem. Biophys. Res. Commun., 293, 1265-1272.
27. Wang, B., Li, J. and Xiao, X. (2000) Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl Acad. Sci. USA, 97, 13714-13719.
28. Harper, S.Q., Hauser, M.A., DelloRusso, C., Duan, D., Crawford, R.W., Phelps, S.F., Harper, H.A., Robinson, A.S., Engelhardt, J.F., Brooks, S.V. et al. (2002) Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med., 8, 253-261.
29. Hartigan-O'Connor, D. and Chamberlain, J.S. (2000) Developments in gene therapy for muscular dystrophy. Microsc. Res. Tech., 48, 223-238.
30. Graham, F.L. and Prevec, L. (1991) Manipulation of Adenovirus Vectors. In Murray, E.J. (ed.), Methods in Molecular Biology, 7: Gene Transfer and Expression Protocols. Humana Press, Clifton, NJ, pp. 109-128.
31. Vincent, N., Ragot, T., Gilgenkrantz, H., Couton, D., Chafey, P., Grégoire, A., Briand, P., Kaplan, J.-C., Kahn, A. and Perricaudet, M. (1993) Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat. Genet., 5, 130-134.
32. Stratford-Perricaudet, L.D., Makeh, I., Perricaudet, M. and Briand, P. (1992) Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest., 90, 626-630.
33. Huard, J., Lochmuller, H., Acsadi, G., Jani, A., Massie, B. and Karpati, G. (1995) The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther., 2, 107-115.
34. Petrof, B.J., Acsadi, G., Jani, A., Massie, B., Bourdon, J., Matusiewicz, N., Yang, L.Y., Lochmüller, H. and Karpati, G. (1995) Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am. J. Respir. Cell Mol. Biol., 13, 508-517.
35. Deconinck, N., Ragot, T., Maréchal, G., Perricaudet, M. and Gillis, J.M. (1996) Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl Acad. Sci. USA, 93, 3570-3574.
36. Yang, L., Lochmuller, H., Luo, J., Massie, B., Nalbantoglu, J., Karpati, G. and Petrof, B.J. (1998) Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Gene Ther, 5, 369-379.
37. Howell, J.M., Lochmuller, H., O'Hara, A., Fletcher, S., Kakulas, B.A., Massie, B., Nalbantoglu, J. and Karpati, G. (1998) High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with inummosuppression. Hum. Gene Ther., 9, 629-634.
38. Clemens, P.R., Kochanek, S., Sunada, Y., Chan, S., Chen, H.H., Campbell, K.P. and Caskey, C.T. (1996) In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther, 3, 965-972.
39. Kumar-Singh, R. and Chamberlain, J.S. (1996) Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum. Mol. Genet., 5, 913-921.
40. Kochanek, S., Clemens, P.R., Mitani, K., Chen, H.H., Chan, S. and Caskey, C.T. (1996) A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl Acad. Sci. USA, 93, 5731-5736.
41. Hartigan-O'Connor, D., Barjot, C., Salvatori, G. and Chamberlain, J.S. (2002) Generation and growth of gutted adenoviral vectors. Meth. Enzymol., 346, 224-246.
42. Chen, H.H., Mack, L.M., Kelly, R., Ontell, M., Kochanek, S. and Clemens, P.R. (1997) Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl Acad. Sci. USA, 94, 1645-1650.
43. Chen, H.H., Mack, L.M., Choi, S.Y., Ontell, M., Kochanek, S. and Clemens, P.R. (1999) DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle. Hum. Gene Ther., 10, 365-373.
44. DelloRusso, C., Scott, J., Hartigan-O'Connor, D., Salvatori, G., Barjot, C., Robinson, A.S., Crawford, R.W., Brooks, S.V. and Chamberlain, J.S. (2002) Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc. Natl Acad. Sci. USA, in press.
45. Roberts, M.L., Wells, D.J., Graham, I.R., Fabb, S.A., Hill, V.J., Duisit, G., Yuasa, K., Takeda, S., Cosset, F.L. and Dickson, G. (2002) Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle. Hum. Mol. Genet., 11, 1719-1730.
46. Shayakhmetov, D.M., Carlson, C.A., Stecher, H., Li, Q., Stamatoyannopoulos, G. and Lieber, A. (2002) A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells. J. Virol., 76, 1135-1143.
47. Dunckley, M.G., Wells, D.J., Walsh, F.S. and Dickson, G. (1993) Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet., 2, 717-723.
48. VandenDriessehe, T., Naldini, L., Collen, D. and Chuah, M.K. (2002) Oncoretroviral and lentiviral vector-mediated gene therapy. Meth. Enzymol., 346, 573-589.
49. Xiao, X., Li, J. and Samulski, R.J. (1996) Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol., 70, 8098-8108.
50. Fisher, K.J., Jooss, K., Alston, J., Yang, Y, Haecker, S.E., High, K., Pathak, R., Raper, S.E. and Wilson, J.M. (1997) Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med., 3, 306-312.
51. Vincent-Lacaze, N., Snyder, R.O., Gluzman, R., Bohl, D., Lagarde, C. and Danos, O. (1999) Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J. Virol., 73, 1949-1955.
52. Chao, H., Liu, Y, Rabinowitz, J., Li, C., Samulski, R.J. and Walsh, C.E. (2000) Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther., 2, 619-623.
53. Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N. and Wilson, J.M. (2001) Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol., 75, 6199-6203.
54. Scott, J.M., Li, S., Harper, S.Q., Welikson, D., Bourque, D., DelloRusso, C., Hauschka, S.D. and Chamberlain, J.S. (2002) Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin. Neuromusc. Disord., in press.
55. Wolff, J.A., Malone, R.W., Williams, P., Chong, W., Acsadi, G., Jani, A. and Felgner, P.L. (1990) Direct gene transfer into mouse muscle in vivo. Science, 247, 1465-1468.
56. Acsadi, G., Dickson, G., Love, D.R., Jani, A., Walsh, F.S., Gurusinghe, A., Wolff, J.A. and Davies, K.E. (1991) Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature, 352, 815-818.
57. Aihara, H. and Miyazaki, J.-I. (1998) Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol., 16, 867.
58. Zhang, G., Budker, V, Williams, P., Subbotin, V. and Wolff, J.A. (2001) Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates. Hum. Gene Ther., 12, 427-438.
59. Liu, F., Nishikawa, M., Clemens, P.R. and Huang, L. (2001) Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA. Mol. Ther, 4, 45-51.
60. Dubowitz, V. (2002) Special Centennial Workshop-101st ENMC International Workshop: Therapeutic Possibilities in Duchenne Muscular Dystrophy, 30th November-2nd December 2001, Naarden, The Netherlands. Neuromusc. Disord., 12, 421-431.
61. Schnell, M.A., Zhang, Y., Tazelaar, J., Gao, G., Yu, Q.C., Qian, R., Chen, S.J., Varnavski, A.N., LeClair, C., Raper, S.E. et al. (2001) Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol. Ther., 3, 708-722.
62. Zoltick, P.W., Chirmule, N., Schnell, M.A., Gao, G.P., Hughes, J.V. and Wilson, J.M. (2001) Biology of E1-deleted adenovirus vectors in nonhuman primate muscle. J. Virol., 75, 5222-5229.
63. Yang, Y., Jooss, K.U., Su, Q., Ertl, H.C. and Wilson, J.M. (1996) Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther., 3, 137-144.
64. Tripathy, S.K., Black, H.B., Goldwasser, E. and Leiden, J.M. (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med., 2, 545-550.
65. Michou, A.I., Santoro, L., Christ, M., Julliard, V, Pavirani, A. and Mehtali, M. (1997) Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther, 4, 473-482.
66. Morral, N., O'Neal, W.K., Rice, K., Leland, M.M., Piedra, P.A., Aguilar-Cordova, E., Carey, K.D., Beaudet, A.L. and Langston, C. (2002) Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum. Gene Ther, 13, 143-154.
67. Zhang, Y., Chirmule, N., Gao, G., Qian, R., Croyle, M., Joshi, B., Tazelaar, J. and Wilson, J.M. (2001) Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol. Ther, 3, 697-707.
68. Zaiss, A.K., Liu, Q., Bowen, G.P., Wong, N.C., Bartlett, J.S. and Muruve, D.A. (2002) Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J. Virol., 76, 4580-4590.
69. Schiedner, G., Morral, N., Parks, R.J., Wu, Y., Koopmans, S.C., Langston, C., Graham, F.L., Beaudet, A.L. and Kochanek, S. (1998) Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity [Erratum (1998) Nat. Genet., 18, 298.] Nat. Genet., 18, 180-183.
70. Reddy, P.S., Sakhuja, K., Ganesh, S., Yang, L., Kayda, D., Brann, T., Pattison, S., Golightly, D., Idamakanti, N., Pinkstaff, A. et al. (2002) Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector. Mol. Ther., 5, 63-73.
71. O'Neal, W.K., Zhou, H., Morral, N., Langston, C., Parks, R.J., Graham, F.L., Kochanek, S. and Beaudet, A.L. (2000) Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector. Mol. Med., 6, 179-195.
72. Hauser, M.A., Robinson, A., Hartigan-O'Connor, D., Williams-Gregory, D.A., Buskin, J.N., Apone, S., Kirk, CJ, Hardy, S., Hauschka, S.D. and Chamberlain, J.S. (2000) Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors. Mol. Ther., 2, 16-25.
73. Hartigan-O'Connor, D., Kirk, C.J., Crawford, R., Mule, J.J. and Chamberlain, J.S. (2001) Immune evasion by muscle-specific gene expression in dystrophic muscle. Mol. Ther, 4, 525-533.
74. Cordier, L., Guang-Ping, G., Hack, A., McNally, E.M., Wilson, J.M., Chirmule, N. and Sweeney, H.L. (2001) Muscle-specific promoters may be neccesary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum. Gene Ther., 12, 205-215.
75. Sarukhan, A., Soudais, C., Danos, O. and Jooss, K. (2001) Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J. Gene Med., 3, 260-270.
76. Cordier, L., Hack, A.A., Scott, M.O., Barton-Davis, E.R., Gao, G., Wilson, J.M., McNally, E.M. and Sweeney, H.L. (2000) Rescue of skeletal muscles of γ-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer. Mol. Ther., 1, 119-129.
77. Donoviel, D.B., Shield, M.A., Buskin, J.N., Haugen, H.S., Clegg, C.H. and Hauschka, S.D. (1996) Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice. Mol. Cell. Biol., 16, 1649-1658.
78. Yuasa, K., Sakamoto, M., Miyagoe-Suzuki, Y., Tanouchi, A., Yamamoto, H., Li, J., Chamberlain, J.S., Xiao, X. and Takeda, S. (2002) Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Gene Ther, in press.
79. + suppressor cells. Ann. Neurol., 23, 493-499.
80. Arahata, K. and Engel, A.G. (1988) Monoclonal antibody analysis of monorruclear cells in myopathics. IV: Cell-mediated cytotoxicity and muscle fiber necrosis. Ann. Neurol., 23, 168-173.
81. Jooss, K., Yang, Y., Fisher, K.J. and Wilson, J.M. (1998) Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol., 72, 4212-4223.
82. Zhang, Y., Chirmule, N., Gao, G. and Wilson, J. (2000) CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells. J. Virol., 74, 8003-8010.
83. Sarukhan, A., Camugli, S., Gjata, B., von Boehmer, H., Danes, O. and Jooss, K. (2001) Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J. Virol., 75, 269-277.
84. Braun, S., Thioudellet, C., Rodriguez, P., Ali-Hadji, D., Perraua F., Accart, N., Balloul, J.-M., Halluard, C., Acres, B., Cavallini, B. et al. (2000) Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice. Gene Ther, 7, 1447-1457.
85. Ferrer, A., Wells, K. and Wells, D. (2000) Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Gene Ther., 7, 1439-1446.
86. Guibinga, G.H., Lochmuller, H., Massie, B., Nalbantoglu, J., Karpati, G. and Petrof, B.J. (1998) Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles. J. Virol., 72, 4601-4609.
87. Greelish, J.P., Su, L.T., Lankford, E.B., Burkman, J.M., Chen, H., Konig, S.K., Mercier, I.M., Desjardins, P.R., Mitchell, M.A., Zheng, X.G. et al. (1999) Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat. Med., 5, 439-443.
88. Cho, W.K., Ebihara, S., Nalbantoglu, J., Gilbert, R., Massie, B., Holland, P., Karpati, G. and Petrof, B.J. (2000) Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum. Gene Ther, 11, 701-714.
89. Douglas, J.T., Rogers, B.E., Rosenfeld, M.E., Michael, S.I., Feng, M. and Curiel, D.T. (1996) Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotechnol., 14, 1574-1578.
90. Wickham, T. (2000) Targeting adenovirus. Gene Ther, 7, 110-114.
91. Bouri, K., Feero, W.G., Myerburg, M.M., Wickham, T.J., Kovesdi, I., Hoffman, E.P. and Clemens, P.R. (1999) Polylysine modification of adenoviral fiber protein enhances muscle cell transduction. Hum. Gene Ther., 10, 1633-1640.
92. Mendell, J.R., Kissel, J.T., Amato, A.A., King, W., Signore, L., Prior, T.W., Sahenk, Z., Besson, S., McAndrew, P.E., Rice, R. et al. (1995) Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med., 333, 832-838.
93. Miller, R.G., Sharma, K.R., Pavlath, G.K., Gussoni, E., Mynhier, M., Lanctot, A.M., Greco, C.M., Steinman, L. and Blau, H.M. (1997) Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve, 20, 469-478.
94. Ferrari, G., Cusella-De Angelis, G., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G. and Mavilio, F. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors [Erratum (1998) Science, 281, 923.] Science, 279, 1528-1530.
95. Gussoni, E., Soneoka, Y., Strickland, C.D., Buzney, E.A., Khan, M.K., Flint, A.F., Kunkel, L.M. and Mulligan, R.C. (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature, 401, 390-394.
96. Jackson, K.A., Mi, T. and Goodell, M.A. (1999) Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl Acad. Sci. USA, 96, 14482-14486.
97. Bertoni, C. and Rando, T.A. (2002) Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum. Gene Ther., 13, 707-718.
98. Hirata, R., Chamberlain, J., Dong, R. and Russell, D.W. (2002) Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat. Biotechnol., 20, 735-738.
99. Kapsa, R., Quigley, A., Lynch, G.S., Steeper, K., Kornberg, A.J., Gregorevic, P., Austin, L. and Byrne, E. (2001) In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum. Gene Ther., 12, 629-642.
100. van Deutekom, J.C., Bremmer-Bout, M., Janson, A.A., Ginjaar, I.B., Baas, F., den Dunnen, J.T. and van Ommen, G.J. (2001) Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum. Mol. Genet., 10, 1547-1554.
101. Mann, C.J., Honeyman, K., Cheng, A.J., Ly, T., Lloyd, F., Fletcher, S., Morgan, J.E., Partridge, T.A. and Wilton, S.D. (2001) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc. Natl Acad. Sci. USA, 98, 42-47.
102. Tinsley, J.M. and Davies, K.E. (1993) Utrophin: a potential replacement for dystrophin? Neuromusc. Disord., 3, 537-539.
103. Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J.M. and Davies, K. (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat. Med., 4, 1441-1444.
104. Rafael, J.A., Tinsley, J.M., Potter, A.C., Deconinck, A.E. and Davies, K.E. (1998) Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat. Genet., 19, 79-82.
105. Wakefield, P.M., Tinsley, J.M., Wood, M.J., Gilbert, R., Karpati, G. and Davies, K.E. (2000) Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther., 7, 201-204.
106. Ebihara, S., Guibinga, G.H., Gilbert, R., Nalbantoglu, J., Massie, B., Karpati, G. and Petrof, B.J. (2000) Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice. Physiol. Genom., 3, 133-144.
107. Gilbert, R., Nalbantoglu, J., Petrof, B.J., Ebihara, S., Guibinga, G.H., Tinsley, J.M., Kamen, A., Massie, B., Davies, K.E. and Karpati, G. (1999) Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum. Gene Ther, 10, 1299-1310.
108. Burton, E.A., Tinsley, J.M., Holzfeind, P.J., Rodrigues, N.R. and Davies, K.E. (1999) A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proc. Natl Acad. Sci. USA, 96, 14025-14030.
109. Gramolini, A.O., Angus, L.M., Schaeffer, L., Burton, E.A., Tinsley, J.M., Davies, K.E., Changeux, J.P. and Jasmin, B.J. (1999) Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proc. Natl Acad. Sci. USA, 96, 3223-3227.
110. Nguyen, H.H., Jayasinha, V., Xia, B., Hoyte, K. and Martin, P.T. (2002) Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Proc. Natl Acad. Sci. USA, 99, 5616-5621.
111. Lumeng, C.N., Phelps, S.F., Rafael, J.A., Cox, G.A., Hutchinson, T.L., Begy, C.R., Adkins, E., Wiltshire, R. and Chamberlain, J.S. (1999) Characterization of dystrophin and utrophin diversity in the mouse. Hum. Mol. Genet., 8, 593-599.